Agilon Health (AGL) Operating Leases (2020 - 2023)

Agilon Health has reported Operating Leases for 4 years, with the latest figure at $10.5 million in Q1 2023.

• For the quarter ending Q1 2023, Operating Leases rose 26.67% year-over-year to $10.5 million; the trailing twelve-month figure through Mar 2023 stood at $10.5 million (up 26.67% YoY), and the FY2022 full-year result was $9.9 million, up 25.06% from the prior year.
• Operating Leases for Q1 2023 stood at $10.5 million, up from $9.9 million in the prior quarter.
• The five-year high for Operating Leases was $11.0 million in Q2 2022, with the low at $5.3 million in Q2 2021.
• Historically, Operating Leases has averaged $8.2 million across 4 years, with a median of $8.1 million in 2021.
• The largest YoY upside for Operating Leases was 106.51% in 2022 against a maximum downside of 25.06% in 2022.
• Agilon Health's Operating Leases stood at $5.5 million in 2020, then surged by 43.5% to $7.9 million in 2021, then advanced by 25.06% to $9.9 million in 2022, then increased by 5.95% to $10.5 million in 2023.
• The last three Operating Leases figures came in at $10.5 million (Q1 2023), $9.9 million (Q4 2022), and $10.3 million (Q3 2022), per Business Quant data.